How Primary Packaging can Accelerate Today's Drug Development & Approval Process

Bormioli Pharma has developed a solid and extensive patient-centric innovation program intended to advise the pharma industry along the entire drug development process, from early stage compatibility assessment up to the production of parts needed for drug fileing, clinical trials and commercialization. In the current healthcare domain where personalized medicine, biosimilars, gene-cell therapies, orphan drugs new formulation are becoming increasingly important, the choice and the development of the most appropriate pharmaceutical primary packaging is fundamental for success. Blending patient knowledge, an innovator DNA and leveraging at the same time on a robust industrial footprint is a distinctive capability and can be instrumental for building valuable co-partnership with the pharmaceutical industry. Bormioli Pharma will share details on its “Invents Department” and how biopharma companies leveraged on our services to accelerate the adoption of their biotechnology-based therapies.